About the Conference
Genvio Conferences invites you to join us at the “5th World Congress on Diabetes and endocrinology”-WCDE 2023 where you will be assured to have a meaningful experience with scholars from around the world. The organizing committee looks forward to meeting you all at November 15-16, 2023.
The Conference relies on the theme of: “To Translate and harness novel therapies in Diabetes and Endocrinology.” Meet the Global Inspiring experts and speakers at our World Congress on Diabetes and endocrinology which will focus in bringing together individuals who have an interest in different fields of Endocrinology, Diabetes and Metabolic Disorders such as Endocrinologists, Diabetologists, Ophthalmologist, Medical Professors, Researchers, Diabetes and Endocrinology Scientists, Practitioners, Physical trainer or Exercise physiologist, Medical students.
This conference is a unique platform for researchers and clinicians to present analysis regarding endocrine and diabetic disease management and complications, exchanging ideas about it and thus contributes to the dissemination of knowledge in the society.
The two days conference will include workshops, symposiums, special keynote sessions conducted by eminent speakers within the sector of medical science related to diabetes and endocrine complications.
The Diabetes Congress 2023 highlights the theme “To Translate and harness novel therapies in Diabetes and Endocrinology” emphasize on the latest advancements in prevention and treatment of various metabolic diseases which may be due to diabetic and endocrine complications and provides robust discussions on methods and strategies related to diagnosis, prevention and management of metabolic disorders as well as explore new ideas and concepts for treatment of Diabetes & Endocrine Complications.
• Exchanging of ideas and networking with renowned leading Diabetologists, endocrinologists, polygenic disease researchers, clinician’s researchers, nurses, polygenic disease and medical professionals and researchers from across the world.
• Medical doctors, health care providers consider the prevention of Diabetes diseases as an essential tool to improve the general health status of the population.
• Learn and discuss about diabetes complications and challenges with our Keynote speakers.
• With seminars, panel discussions, roundtable conference discussions, and workshops, we tend to cover each and every topic from top to bottom, from global macro issues to tactical issues.
Global diabetes market is expected to grow at a CAGR of 7.6% percent for the forecasted period of 2018-2023. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 8.9%. Some of the top selling diabetic drugs include Lantus (Sanofi), Januvia (Merck And Co), Humalog (Eli Lily And Co), Novorapid (Novo Nordisk), Levemir (Novo Nordisk), Victoza (Novo Nordisk), Janumet (Merck And Co.), Novolog (Novo Nordisk), Humalin (Eli Lily And Co.) And Galvus (Novartis). With the diabetic population expected to cross the 350 million market by 2030 the market is expected to show strong growth rate. Diabetic drugs are highly priced which could be one of the major drawbacks.
Endocrinology is the part of solution managing endocrine and metabolic issue. The endocrine system is made of hormone-producing glands, such as the thyroid, parathyroid, pancreas, ovaries, testes, adrenals, pituitary, and hypothalamus. These hormones control reproduction, metabolism, and growth and development. Most endocrine issues are unending and require ceaseless treatment. Some commonly treated endocrine disorders include diabetes mellitus, thyroid, and hyper parathyroid disorders, and osteoporosis Some less regular however genuine endocrine issue incorporates, yet are not constrained to Addison's illness, Cushing's disorder, pheochromocytoma, and clusters of sexual advances.
In the United States, the most well-known endocrine illness is diabetes mellitus. Diabetes mellitus is a gathering of sicknesses arranged by a lack of insulin creation or the capacity of the body to utilize it. According to the American Diabetes Association, in 2010, 25.8 million children and adults in the United States (8.3% of the population) have diabetes. The study and treatment of diabetes have made endocrinology/ metabolic one of the most in-demand and important medical sects.
All abstracts must be written exclusively in English (including the title, abstract text, author names and affiliations).
Modes of Presentation:
- Oral presentation
- Poster presentation
Visa Information
- Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.
- Genvio conferences will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.
- Important note for failed visa applications: Visa issues cannot come under the consideration of cancellation policy of including the inability to obtain a visa.
Scientific Sessions
- Diabetes and vascular diseases
- Diabetes and Nutrition
- Biomarkers of Diabetes Mellitus
- Pediatric diabetes
- Endocrine Disorders
- Diabetes mellitus type 2
- Diabetes mellitus type 1
- Pediatric diabetes
- Complications associated with Diabetes
- Diabetic Cardiomyopathy
- Diabetic Nephropathy
- Diabetic Retinopathy
- Diabetic Foot and ankle
- Gestational diabetes Mellitus
- Advanced Technologies for the Treatment of Diabetes
- Endocrinology and Metabolism
- Endocrinology and Diabetes
- Adrenal and Thyroid Disorders
- Neuroendocrinology and Pituitary Disorders
- Diabetes risk management
- Clinical Endocrinology
- Pediatric Endocrinology
- Endocrinology Glands and Hormones
- Diabetic Retinopathy
- Diabetes: Oral complications
- Diabetics and Pancreas
- Diabetes and Gastroparesis
- Current Trends & Advancements in Diabetes Research
- Diabetes Care and prevention
- Neuroendocrinology
- Diagnosis of Diabetes
- Alternative therapies
- Global Diabetes Market
- Diabetes and Periodontitis
- Diabetes and HHNS
- Diabetes and DKA
- Hyperglycemia and Hypoglycemia
- Islet Transplantation
- Metabolic Changes in Diabetes
- Diabetic Coma and Nursing
- Obesity and Metabolism
- Diabetes mellitus and obesity
- Endocrinology Glands and Hormones
- Diabetic Encephalopathy
- Obesity Surgery
Committee
Hayat Mushcab
Johns Hopkins Aramco Healthcare, Saudi Arabia
Lacombe Veronique
Oklahoma State University, USA
Lisa Maness
Winston-Salem State University, USA
Regina C Spadari
Universidade Federal de São Paulo (UNIFESP), Brazil
Ishii Douglas
Colorado State University, USA
Andrea Belén Zeped Pérez
Autonomous University of Chile, Chile
Sriram Seshadri
Nirma University, India
Alan J Stewart
University of St Andrews, UK
Alice Jaya Pradha Cheekurthy
Maris Stella College, India
Enza Mozzillo
University of Naples, Italy
Nilmini Wickramasinghe
Swinburne University of Technology, Australia
Chih Hao Wang
China Medical University Taichung, Taiwan
Konrad Talbot
Loma Linda University School of Medicine, USA
Omo Ojo
University of Greenwich, UK
Loo Say Chye Joachim
Nanyang Technological University, Singapore
Amr T. M. Saeb
Professor and Lead Scientific consultant, Zifo Rnd, UK
P. Revathi
Kongunadu Arts and Science College, India
Sutapa Mukherjee
Siksha Bhavana (Institute of Science), Visva-Bharati, India
Yong Zhao
Founder and CEO of Throne Biotechnologies, USA
Giribabu Nelli
University of Malaya, Malaysia
Rajeev Taliyan
Department of Pharmacy, BITS-Pilani, India
Anupama Mittal
Birla Institute of Technology and Science, Rajasthan, India
Paola Quaresima
Magna Graecia University of Catanzaro, Italy
Jintu Kurian
Swami Vivekanada Yoga Anusandhana Samsthana (S-VYASA), Bangalore, India
Aleksandar Jeremic
The George Washington University, USA
Pinki Roy
National Institute of Technology, Assam, India
Swati Sharma
Vellore Institute of Technology, Chennai
Vinaytosh Mishra
Gulf Medical University, UAE
Baharudin Ibrahim
Universiti Malaya, Malaysia
Spinelli Sonia
University of Genoa, Italy
Laura Sturla
University of Genova, Italy
Rashmi Tupe
Symbiosis School of Biological Sciences (SSBS), India
Jeena gupta
Lovely Professional University, India
Shyh-Yu Shaw
National Cheng Kung University, Taiwan
Raghu K.G
National Institute for Interdisciplinary Science and Technology, India
Raman Puri
Founder & Chairman, Lipid Association of India, India
Shouhartha Choudhury
Assam University, India
Vijayalakshmi Venkatesan
National Institute of Nutrition, ICMR, India
Past Conference Information - Diabetes and endocrinology - 2022
2nd World Congress on Diabetes and endocrinology during March 07-08, 2022
Genvio Conferences hosted “2nd World Congress on Diabetes and endocrinology” during March 07-08, 2022. The conferences were organized with a focus on the theme “To Translate and harness novel therapies in Diabetes and Endocrinology” was a great success where eminent keynote speakers from various reputed universities made their resplendent presence and addressed the gathering.
The event proceedings were carried out through several Scientific-sessions and plenary lectures, Genvio group would like to express a sincere thankfulness to all the Honourable guests and Keynote Speakers of 2nd World Congress on Diabetes and endocrinology. We would like to convey a warm gratitude to all the Honourable guests and Keynote Speakers of Diabetes & Endocrinology.
WCDE 2022 committee would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers, Sutapa Mukherjee, Siksha Bhavana (Institute of Science), VisvaBharati (A Central University), Santiniketan, India; Yong Zhao, Founder and CEO of Throne Biotechnologies, USA; Amr T. M. Saeb, Professor and Lead Scientific consultant at Zifo Rnd, UK; Paola Quaresima, Magna Graecia University of Catanzaro, Italy; Revathi Ponnusamy, Kongunadu Arts and Science College, India; Giribabu Nelli, University of Malaya, Malaysia: Rajeev Taliyan, BITS-Pilani, India have given a wonderful talk which allows the delegates and other attendees to gain the knowledge about main course of the event.
Genvio conferences also took the privilege of felicitating WCDE 2022 Organizing Committee, Keynote Speakers, Plenary Speakers, Chairs and Co-Chairs, Young Researchers and other attendees whose support made the conference a great success.
We also would like to thank all our Speakers, Poster Presenters and Delegates for taking out your time and sharing their research work with our peer network. We are very glad to have shared a great relationship with all these Attendees, associations and we hope to see even greater support in our upcoming events.
A series of lectures by distinguished professionals discussed To Translate and harness novel therapies in Diabetes and Endocrinology.
World Congress on Diabetes and Endocrinology hosted by Genvio group held during September 15-16, 2021.
Active participation and generous response were received from the Organizing Committee Members, as well as from eminent scientists, talented researchers and young student community.
Researchers and students who attended from different parts of the world have made the conference one of the most successful and productive events in 2021.
The conference was marked by the presence of renowned scientists, talented young researchers, students and business delegates driving the two days event into the path of success with thought-provoking keynote and plenary presentations highlighting the theme “Translate and harness novel therapies in Diabetes and Endocrinology”
Genvio group has taken the privilege of felicitating WCDE 2021 Conference Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event.
Genvio group, on behalf of the conference sponsor, appreciates all the participants who put their efforts for this event and sincerely wishes them success in future endeavours.
The esteemed guests, Keynote speakers, well-known researchers, and delegates shared their innovative research and vast experience through their fabulous presentations at the podium of grand Diabetes and Endocrinology 2021 Conference.
We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums.
WCDE 2021 committee would like to convey a warm gratitude to all the Honorable guests and Keynote Speakers Lisa Maness from Winston-Salem State University, USA; Sriram Seshadri, from Nirma University, India; Alan Stewart from University of St Andrews, UK; Alice Jaya Pradha Cheekurthy from Acharya Nagarjuna University, India; Chih Hao Wang from China Medical University, Taichung, Taiwan; Omo Ojo from University of Greenwich, London; Konrad Talbot from Loma Linda University School of Medicine, USA; Andrea Belén Zeped Pérez from Autonomous University of Chile, Chile, India; have given a wonderful talk which allows the delegates and other attendees to gain the knowledge about main course of the event.
We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance towards the success of Diabetes and Endocrinology 2021.
With the unique feedbacks from the conference, Genvio group would like to announce the commencement of the 2nd World Congress on Diabetes and Endocrinology during January 24-25, 2022
Let us meet again @ WCDE 2022
